StonvexLoading…
StonvexStonvexStonvexCore line items from SCKT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $15.08M | $18.76M | $17.03M | $21.24M |
Operating Income | $-3.22M | $-2.46M | $-3.12M | $-446.02K |
Net Income | $-14.38M | $-2.24M | $-1.92M | $86.93K |
EPS (Diluted) | $-1.81 | $-0.30 | $-0.27 | $0.01 |
Total Assets | $14.44M | $27.35M | $28.74M | $28.60M |
Total Liabilities | $10.16M | $9.19M | $9.32M | $8.28M |
Cash & Equivalents | $2.03M | $2.49M | $2.83M | $3.62M |
Free Cash Flow OCF − CapEx | $-1.79M | $-1.31M | $-2.12M | $-1.29M |
Shares Outstanding | 7.98M | 7.61M | 7.34M | 7.09M |